Home/Filings/4/0001140361-12-008505
4//SEC Filing

Doi Tracey 4

Accession 0001140361-12-008505

CIK 0001420031other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 8:26 PM ET

Size

7.9 KB

Accession

0001140361-12-008505

Insider Transaction Report

Form 4
Period: 2012-02-10
Doi Tracey
Director
Transactions
  • Other

    Convertible Promissory Note

    2012-02-10$108000.00/sh30,000 total
    Exercise: $3.60From: 2012-02-10Exp: 2013-02-10Common Stock (30,000 underlying)
  • Other

    Warrant

    2012-02-10+30,00030,000 total
    Exercise: $1.00From: 2012-02-10Exp: 2015-02-10Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]The principal amount of the Convertible Promissory Note (the "Note") plus unpaid accrued interest (8% per annum) is convertible into shares of the Issuer's common stock. The 30,000 shares represents the number of shares into which the principal amount of the Note may be converted ("Convertible Shares").
  • [F2]Warrant, issued in connection with the Note, to purchase 30,000 shares of common stock with an exercise price of $1.00 per share.

Documents

1 file

Issuer

EMMAUS LIFE SCIENCES, INC.

CIK 0001420031

Entity typeother

Related Parties

1
  • filerCIK 0001527766

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:26 PM ET
Size
7.9 KB